Cargando…

Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia

BACKGROUND: Naturally occurring autoantibodies against amyloid-β (nAbs-Aβ) have been shown to exert beneficial effects on transgenic Alzheimer’s disease (AD) animals in vivo and on primary neurons in vitro. Not much is known about their effect on microglial cells. Our aim was to investigate the effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gold, Maike, Mengel, David, Röskam, Stephan, Dodel, Richard, Bach, Jan-Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599240/
https://www.ncbi.nlm.nih.gov/pubmed/23317003
http://dx.doi.org/10.1186/1742-2094-10-5
_version_ 1782262918524436480
author Gold, Maike
Mengel, David
Röskam, Stephan
Dodel, Richard
Bach, Jan-Philipp
author_facet Gold, Maike
Mengel, David
Röskam, Stephan
Dodel, Richard
Bach, Jan-Philipp
author_sort Gold, Maike
collection PubMed
description BACKGROUND: Naturally occurring autoantibodies against amyloid-β (nAbs-Aβ) have been shown to exert beneficial effects on transgenic Alzheimer’s disease (AD) animals in vivo and on primary neurons in vitro. Not much is known about their effect on microglial cells. Our aim was to investigate the effect of nAbs-Aβ on amyloid-β (Aβ)-treated microglial cells in vitro with respect to cell viability, stress pathways, cytokine production and phagocytotic abilities and whether these effects can be conveyed to neurons. METHODS: Primary microglial cells isolated from Swiss Webster mouse mesencephalons on embryonic day 13.5 were pretreated with nAbs-Aβ and then treated with Aβ oligomers. After 3 hours, phagocytosis as well as western blot analysis were evaluated to measure the amount of phagocytized Aβ. Cell viability was analyzed using an MTT assay 24 hours after treatment. Pro-inflammatory cytokines in the supernatants were analyzed with ELISAs and then we treated primary neuronal cells with these conditioned microglia supernatants. Twenty-four hours later we did a MTT assay of the treated neurons. We further investigated the effect of a single nAbs-Aβ administration on Tg2576 mice in vivo. RESULTS: Upon co-administration of Aβ and nAbs-Aβ no change in microglia viability was observed. However, there was an increase in phosphorylated p38 protein level, an increase in the pro-inflammatory cytokines TNF-α and IL-6 and an increase in Aβ uptake by microglial cells. Treatment of primary neurons with conditioned microglia medium led to a 10% improvement in cell viability when nAbs-Aβ were co-administered compared to Aβ-treated cells alone. We were unable to detect changes in cytokine production in brain lysates of Tg2576 mice. CONCLUSIONS: We provide evidence on the mechanism of action of nAbs-Aβ on microglia in vitro. Interestingly, our in vivo data indicate that nAbs-Aβ administration should be considered as a therapeutic strategy in AD, since there is no inflammatory reaction.
format Online
Article
Text
id pubmed-3599240
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35992402013-03-17 Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia Gold, Maike Mengel, David Röskam, Stephan Dodel, Richard Bach, Jan-Philipp J Neuroinflammation Research BACKGROUND: Naturally occurring autoantibodies against amyloid-β (nAbs-Aβ) have been shown to exert beneficial effects on transgenic Alzheimer’s disease (AD) animals in vivo and on primary neurons in vitro. Not much is known about their effect on microglial cells. Our aim was to investigate the effect of nAbs-Aβ on amyloid-β (Aβ)-treated microglial cells in vitro with respect to cell viability, stress pathways, cytokine production and phagocytotic abilities and whether these effects can be conveyed to neurons. METHODS: Primary microglial cells isolated from Swiss Webster mouse mesencephalons on embryonic day 13.5 were pretreated with nAbs-Aβ and then treated with Aβ oligomers. After 3 hours, phagocytosis as well as western blot analysis were evaluated to measure the amount of phagocytized Aβ. Cell viability was analyzed using an MTT assay 24 hours after treatment. Pro-inflammatory cytokines in the supernatants were analyzed with ELISAs and then we treated primary neuronal cells with these conditioned microglia supernatants. Twenty-four hours later we did a MTT assay of the treated neurons. We further investigated the effect of a single nAbs-Aβ administration on Tg2576 mice in vivo. RESULTS: Upon co-administration of Aβ and nAbs-Aβ no change in microglia viability was observed. However, there was an increase in phosphorylated p38 protein level, an increase in the pro-inflammatory cytokines TNF-α and IL-6 and an increase in Aβ uptake by microglial cells. Treatment of primary neurons with conditioned microglia medium led to a 10% improvement in cell viability when nAbs-Aβ were co-administered compared to Aβ-treated cells alone. We were unable to detect changes in cytokine production in brain lysates of Tg2576 mice. CONCLUSIONS: We provide evidence on the mechanism of action of nAbs-Aβ on microglia in vitro. Interestingly, our in vivo data indicate that nAbs-Aβ administration should be considered as a therapeutic strategy in AD, since there is no inflammatory reaction. BioMed Central 2013-01-14 /pmc/articles/PMC3599240/ /pubmed/23317003 http://dx.doi.org/10.1186/1742-2094-10-5 Text en Copyright ©2013 Gold et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Gold, Maike
Mengel, David
Röskam, Stephan
Dodel, Richard
Bach, Jan-Philipp
Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia
title Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia
title_full Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia
title_fullStr Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia
title_full_unstemmed Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia
title_short Mechanisms of action of naturally occurring antibodies against β-amyloid on microglia
title_sort mechanisms of action of naturally occurring antibodies against β-amyloid on microglia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599240/
https://www.ncbi.nlm.nih.gov/pubmed/23317003
http://dx.doi.org/10.1186/1742-2094-10-5
work_keys_str_mv AT goldmaike mechanismsofactionofnaturallyoccurringantibodiesagainstbamyloidonmicroglia
AT mengeldavid mechanismsofactionofnaturallyoccurringantibodiesagainstbamyloidonmicroglia
AT roskamstephan mechanismsofactionofnaturallyoccurringantibodiesagainstbamyloidonmicroglia
AT dodelrichard mechanismsofactionofnaturallyoccurringantibodiesagainstbamyloidonmicroglia
AT bachjanphilipp mechanismsofactionofnaturallyoccurringantibodiesagainstbamyloidonmicroglia